Journal profile
JPSCR Journal of Pharmaceutical Science and Clinical Research
ISSN 2503-331X · Universitas Sebelas Maret · Indonesia
JPSCR Journal of Pharmaceutical Science and Clinical Research: fully open access; APC about USD 70; review about 16 weeks (community reports); 27 articles in 2025.
Scope
Aims, scope and focus
JPSCR Journal of Pharmaceutical Science and Clinical Research is published by Universitas Sebelas Maret. By OpenAlex counts of its recent articles, its largest topics are Medicinal Plant Research, Pharmacy and Medical Practices and Essential Oils and Antimicrobial Activity, together about 34.7% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
JPSCR: Journal of Pharmaceutical Science and Clinical Research (e-ISSN 2503-331x) is an open-access, peer-reviewed journal that offers a forum for publishing original research articles from contributors and for reporting novel technology news related to pharmaceutical science and clinical research. Since 2021, JPSCR has been published three times per year, every April, August, and December. Scientific articles dealing with natural products, the pharmaceutical science-industry, and clinical research are particularly welcome. The journal encompasses research articles, original research reports, reviews, short communications, and scientific commentaries in pharmaceutical science and clinical research, including formulation and pharmaceutical product evaluation, pharmacology, biopharmaceutics, drug delivery, pharmacokinetics, and nanotechnology, along with either natural products or active pharmaceutical ingredients. JPSCR also accepts papers in clinical research, e.g., pharmacoepidemiology, clinical pharmacy, pharmacoeconomy, and pharmacovigilance. Since July 2020, JPSCR has not received articles related to pharmaceutical management, pharmaceutical social behavior & and administration.
From the journal's Aims & Scope
Editor-in-chief Dinar SariPublisher website
Editorial board by country: 1 in mainland China (about 5%); most named Indonesia 17, Mainland China 1, Australia 1, Malaysia 1, Pakistan 1 (21 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medicinal Plant ResearchAgricultural and Biological Sciences18.2%
- Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics8.4%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences8.1%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics5.4%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.4%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics4.4%
- Antibiotic Use and ResistanceImmunology and Microbiology4.4%
- Pharmaceutical Practices and Patient OutcomesMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ScopusPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 15OpenAlex ·
- i10-index
- 30OpenAlex ·
- 2-year mean citedness
- 0.46OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 217 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 8 | 8 | 50 |
| 2025 | 27 | 27 | 94 |
| 2024 | 26 | 26 | 146 |
| 2023 | 32 | 32 | 278 |
| 2022 | 29 | 29 | 172 |
| 2021 | 28 | 28 | 94 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 70 / IDR 1,000,000 | No | CC BY-SA | |
| OpenAlex | IDR 750,000 | — | — | |
| LetPub | USD 70 / IDR 1,000,000 | No | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- 100–250 words
- Reference style
- APA
- Templates
- Word
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Optional
Article types accepted8
- case studyJPSCR publishes original research article, case study, and short communication.Length not stated
- original research articleJPSCR publishes original research article, case study, and short communication.Length not stated
- original research reportsJPSCR encompasses research articles, original research reports, reviews, short communications, and scientific commentariesLength not stated
- research articlesJPSCR encompasses research articles, original research reports, reviews, short communications, and scientific commentariesLength not stated
- reviewsJPSCR encompasses research articles, original research reports, reviews, short communications, and scientific commentariesLength not stated
- scientific commentariesJPSCR encompasses research articles, original research reports, reviews, short communications, and scientific commentariesLength not stated
- short communicationJPSCR publishes original research article, case study, and short communication.Length not stated
- short communicationsJPSCR encompasses research articles, original research reports, reviews, short communications, and scientific commentariesLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism
- AI use
AI-generated content must not exceed 20%; a Declaration of AI Use must be included before the References list. Model summary
JPSCR announces a new editorial policy regulating the use of Artificial Intelligence (AI). Authors are required to ensure that AI-generated content does not exceed 20%. Authors must also include a Declaration of AI Use before the References list.
Source ↗Publisher website ·- Authorship Authorship of the Paper
Manuscripts must be written in Indonesian language, but English is more preferable Model summary
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The …
Source ↗Publisher website ·- Conflicts of interest Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.
Source ↗Publisher website ·- Data availability Data Access and Retention
Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.
Source ↗Publisher website ·- Publication ethics Publication Ethics and Malpractice Statement
Journal of Pharmaceutical Science and Clinical Research (e-ISSN 2503-331x) is a peer-reviewed journal published by Department of Phamacy, Faculty of Mathematics and Natural Sciences, Universitas Sebelas Maret. This statement clarifies the ethical behavior of all parties involved in the act of publishing an article in this journal, including the author, the chief editor, the Editorial Board, the pe…
Source ↗Publisher website ·- License & copyright Copyright Notice
An author who publishes in the Journal of Pharmaceutical Science and Clinical Research (JPSCR) agrees to the following terms: Author retains the copyright and grants the the journal the right of first publication of the work simultaneously licensed under the Creative Commons Attribution-ShareAlike 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and …
Source ↗Publisher website ·- Open access Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Source ↗Publisher website ·- Peer review Peer Review Process
Double-blind peer review with at least 2 reviewers Model summary
JPSCR is an open access and peer-reviewed journal published by Pharmacy Department, Universitas Sebelas Maret, jointly with Ikatan Apoteker Indonesia (IAI) Pengurus Cabang Kota Surakarta. The research article submitted to this online journal will be peer-reviewed (double-blind review process) at least 2 (two) reviewers. The final decision of articles acceptance will be made by Editors according to…
Source ↗Publisher website ·- Plagiarism Plagiarism Checker
To ensure that the articles are free from plagiarism, Journal of Pharmaceutical Science and Clinical Research (JPSCR) using plagiarism software by Turnitin.com. More detail visit: https://www.turnitin.com/login_page.asp?lang=en_us
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Universitas Sebelas Maret
- Country or region
- Indonesia
- Language
- Indonesian, English
- ISSN
- 2503-331X
- Latest issue on the website
- Volume 11, Issue 2 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about JPSCR Journal of Pharmaceutical Science and Clinical Research
How long does peer review take at JPSCR Journal of Pharmaceutical Science and Clinical Research?
Authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of JPSCR Journal of Pharmaceutical Science and Clinical Research?
According to the journal's author guidelines: Abstract: 100–250 words; Reference style: APA; Templates: Word; First submission: Free format: the journal's layout is not required; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of JPSCR Journal of Pharmaceutical Science and Clinical Research based?
Of the 21 board members whose country the journal's board page names, 1 (about 5%) are in mainland China; the countries named most often are Indonesia (17), Mainland China (1) and Australia (1). Counted from the institutions listed on the board page; for reference only.
Which databases index JPSCR Journal of Pharmaceutical Science and Clinical Research?
According to LetPub and DOAJ records, JPSCR Journal of Pharmaceutical Science and Clinical Research is indexed in DOAJ. The journal's website also lists Scopus; that list has not been checked against each database.
Is JPSCR Journal of Pharmaceutical Science and Clinical Research open access, and what is the APC?
JPSCR Journal of Pharmaceutical Science and Clinical Research is a fully open-access journal. APC about USD 70.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .